THE CHANDLER PROJECT JOINS GLOBAL GENES RARE-X PROGRAM
SOURCE: VISEN Pharmaceuticals (Nov 16th, 2023, Shanghai, China) – VISEN Pharmaceuticals (VISEN), an innovative biopharmaceutical company focused on endocrine diseases, is pleased to announce the topline results from the ACcomplisH…
Obtained from UBMD Physicians’ Group website. This article was written by Dirk Hoffman and published on November 9, 2023. Teresa Quattrin, MD, UB Distinguished Professor ofΒ pediatrics, is a co-author on…
COPENHAGEN, Denmark,Β Feb. 28, 2019Β (GLOBE NEWSWIRE) —Β Ascendis Pharma A/SΒ (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransConβ’Β technology to address significant unmet medical needs, today announced that theΒ U.S. Food and Drug…
